- Home
- Publications
- Publication Search
- Publication Details
Title
Update on the Development of MNK Inhibitors as Therapeutic Agents
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-09-18
DOI
10.1021/acs.jmedchem.1c00368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E
- (2021) Ram Kumar et al. ANTIVIRAL RESEARCH
- ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation
- (2021) Hui-er Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma
- (2021) Xin-Yu Ke et al. ONCOGENE
- Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation
- (2021) Joseph-Patrick W. E. Clarke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Topography of transcriptionally active chromatin in glioblastoma
- (2021) Liang Xu et al. Science Advances
- A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease
- (2021) Joseph P. Clarke et al. Frontiers in Molecular Biosciences
- Progress in developing MNK inhibitors
- (2021) Xin Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2
- (2020) Jacek Kwiatkowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nicotinamide–Ponatinib Analogues as Potent Anti-CML and Anti-AML Compounds
- (2020) Elizabeth Larocque et al. ACS Omega
- Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis
- (2020) Jianling Xie et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
- (2020) Celia Pinto-Díez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition
- (2020) Vivek Jeevakumar et al. JOURNAL OF NEUROPHYSIOLOGY
- Rescue of oxytocin response and social behaviour in a mouse model of autism
- (2020) Hanna Hörnberg et al. NATURE
- Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity
- (2020) Lauren Y. Sandeman et al. Molecular Metabolism
- Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity
- (2020) Thao N.D. Pham et al. Cancers
- The Impact of ALS-Associated Genes hnRNPA1, MATR3, VCP and UBQLN2 on the Severity of TDP-43 Aggregation
- (2020) Ana Bajc Česnik et al. Cells
- Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia
- (2020) Liang-Chieh Chen et al. JOURNAL OF NATURAL PRODUCTS
- Targeting translation
- (2020) Katharine H. Wrighton NATURE REVIEWS DRUG DISCOVERY
- Antisense Oligonucleotides As Potential Therapeutics for Type 2 Diabetes
- (2020) Suxiang Chen et al. Nucleic Acid Therapeutics
- Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain
- (2020) Muhammad Saad Yousuf et al. PHARMACOLOGICAL REVIEWS
- Therapeutic Antisense Oligonucleotides Are Coming of Age
- (2019) C. Frank Bennett Annual Review of Medicine
- Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation
- (2019) Theodosia Charitou et al. BRITISH JOURNAL OF CANCER
- Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G
- (2019) Erin E. Gallagher et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated β-Catenin Activation
- (2019) Weijia Zhang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma
- (2019) Min Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and evaluation of 2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione derivatives as Mnk inhibitors
- (2019) Ahmed M. Abdelaziz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
- (2019) Vincenzo Teneggi et al. CTS-Clinical and Translational Science
- Discovery of novel Mnk inhibitors using mutation‐based induced‐fit virtual high‐throughput screening
- (2019) Rama K. Mishra et al. Chemical Biology & Drug Design
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
- (2018) Yonghui Sun et al. CELL RESEARCH
- Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
- (2018) Chengwei Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phthalimide conjugations for the degradation of oncogenic PI3K
- (2018) Wenlu Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
- (2018) Siegfried H. Reich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia
- (2018) Haiyan Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Delineating the role of cooperativity in the design of potent PROTACs for BTK
- (2018) Adelajda Zorba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
- (2018) Argel Aguilar-Valles et al. Nature Communications
- Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells
- (2018) Ella Lineham et al. Oncotarget
- A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1
- (2018) Yumi Matsui et al. Acta Crystallographica Section F-Structural Biology Communications
- eIF4E Phosphorylation in Prostate Cancer
- (2018) Leandro S. D'Abronzo et al. NEOPLASIA
- Abstract 3855: Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response
- (2018) Craig R. Stumpf et al. CANCER RESEARCH
- Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold
- (2018) Xin Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
- (2018) Inês S. Amorim et al. Frontiers in Genetics
- eIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity
- (2018) Sonali Uttam et al. Frontiers in Genetics
- Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers
- (2017) Ella Lineham et al. Future Medicinal Chemistry
- The MNK–eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain
- (2017) Jamie K. Moy et al. JOURNAL OF NEUROSCIENCE
- Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
- (2017) Jonathan B. Bell et al. MOLECULAR CANCER RESEARCH
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation
- (2017) Brian C. Avanzino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
- (2017) Christos Vaklavas et al. Frontiers in Oncology
- Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
- (2016) Michal Grzmil et al. CELLULAR SIGNALLING
- Unveiling new chemical scaffolds as Mnk inhibitors
- (2016) Sarah Diab et al. Future Medicinal Chemistry
- Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
- (2016) Wooseok Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells
- (2016) Joseph Cherian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas
- (2016) Weibing Fan et al. JOURNAL OF NEURO-ONCOLOGY
- MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma
- (2016) J. B. Bell et al. MOLECULAR CANCER RESEARCH
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding
- (2015) James E. Beggs et al. BIOCHEMICAL JOURNAL
- Differential Requirements for eIF4E Dose in Normal Development and Cancer
- (2015) Morgan L. Truitt et al. CELL
- Nonsurgical treatment of recurrent glioblastoma
- (2015) O. Gallego Current Oncology
- An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis
- (2015) Theodosia Teo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation
- (2015) Mingfeng Yu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dynamical insights of Mnk2 kinase activation by phosphorylation to facilitate inhibitor discovery
- (2015) Malika Kumarasiri et al. Future Medicinal Chemistry
- Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
- (2015) H Wu et al. LEUKEMIA
- Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer
- (2015) K. Kumar et al. MOLECULAR CANCER RESEARCH
- Knockdown of eukaryotic translation initiation factor 4E suppresses cell growth and invasion, and induces apoptosis and cell cycle arrest in a human lung adenocarcinoma cell line
- (2015) BAOFU CHEN et al. Molecular Medicine Reports
- Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations
- (2014) Srinivasaraghavan Kannan et al. BIOCHEMISTRY
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- MAP Kinase-Interacting Kinases—Emerging Targets against Cancer
- (2014) Sarah Diab et al. CHEMISTRY & BIOLOGY
- Discovery of 5-(2-(Phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
- (2014) Sarah Diab et al. ChemMedChem
- The Herpes Simplex Virus 1 Virion Host Shutoff Protein Enhances Translation of Viral Late mRNAs by Preventing mRNA Overload
- (2014) B. Dauber et al. JOURNAL OF VIROLOGY
- Induction of Viral, 7-Methyl-Guanosine Cap-Independent Translation and Oncolysis by Mitogen-Activated Protein Kinase-Interacting Kinase-Mediated Effects on the Serine/Arginine-Rich Protein Kinase
- (2014) M. C. Brown et al. JOURNAL OF VIROLOGY
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- Synaptic proteins and receptors defects in autism spectrum disorders
- (2014) Jianling Chen et al. Frontiers in Cellular Neuroscience
- Autism genetics
- (2013) Antonio M. Persico et al. BEHAVIOURAL BRAIN RESEARCH
- Rational Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by Tuning the Reactivity of an Enamide Michael Acceptor
- (2013) Jin Xu et al. ChemMedChem
- hnRNP A1: The Swiss Army Knife of Gene Expression
- (2013) Jacques Jean-Philippe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
- (2013) S. Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational Optimization of Conformational Effects Induced By Hydrocarbon Staples in Peptides and their Binding Interfaces
- (2013) Dilraj Lama et al. Scientific Reports
- LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
- (2012) S. Betty Yan et al. INVESTIGATIONAL NEW DRUGS
- Cap-Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target
- (2012) Yan Jia et al. MEDICINAL RESEARCH REVIEWS
- Autism-related deficits via dysregulated eIF4E-dependent translational control
- (2012) Christos G. Gkogkas et al. NATURE
- Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway
- (2012) L Adesso et al. ONCOGENE
- Improved eIF4E Binding Peptides by Phage Display Guided Design: Plasticity of Interacting Surfaces Yield Collective Effects
- (2012) Weizhuang Zhou et al. PLoS One
- Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases
- (2011) B. W. Konicek et al. CANCER RESEARCH
- MAP Kinase-Interacting Kinase 1 Regulates SMAD2-Dependent TGF- Signaling Pathway in Human Glioblastoma
- (2011) M. Grzmil et al. CANCER RESEARCH
- Exploring Aigialomycin D and Its Analogues as Protein Kinase Inhibitors for Cancer Targets
- (2011) Jin Xu et al. ACS Medicinal Chemistry Letters
- Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues
- (2010) Georgios Boukakis et al. BMC CANCER
- Sumoylation of eIF4E activates mRNA translation
- (2010) Xiang Xu et al. EMBO REPORTS
- IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells
- (2010) Yijiang Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC2 Promotes eIF4E Sumoylation and Activates mRNA Translation Gene Specifically
- (2010) Xiang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
- (2010) L. Furic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- eIF4E: New Family Members, New Binding Partners, New Roles
- (2009) Robert E. Rhoads JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells
- (2008) Andrea Bianchini et al. CARCINOGENESIS
- The Autistic Neuron: Troubled Translation?
- (2008) Raymond J. Kelleher et al. CELL
- eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling
- (2008) A. Soni et al. MOLECULAR CANCER THERAPEUTICS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
- (2007) Robert M. Rowlett et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More